Skip to main content
Fig. 1 | Journal of Inflammation

Fig. 1

From: Dynamics of soluble vascular endothelial growth factor receptors and their ligands in aqueous humour during ranibizumab for age-related macular degeneration

Fig. 1

Profile of the mean BCVA and mean CMT after IRI in patients with AMD. a Mean BCVA improved significantly from log MAR 0.39 ± 0.34 to log MAR 0.28 ± 0.33 at 1 month (p = 0.002) and to log MAR 0.25 ± 0.36 at 2 months (p = 0.004). b Mean CMT decreased significantly from 401 ± 216 μm to 296 ± 199 μm at 1 month (p < 0.001) and to 267 ± 161 μm at 2 months (P < 0.001)

Back to article page

Journal of Inflammation

ISSN: 1476-9255

Contact us